EPISODE · Jun 13, 2021 · 14 MIN
BRAIN Biotech AG Deep Dive The CRISPR Cas9 Opportunity with IR
from Investor Insights from CEOs & CFOs | seat11a · host seat11a.com
BRAIN Biotech AG Deep Dive: Key TakeawaysAbout the Company Discover how BRAIN Biotech AG, a leading European industrial biotechnology company, drives the biologization of industry and contributes to a more sustainable economy in this comprehensive video presentation. Join Michael Schneiders, IR, as he takes you through the company’s cutting-edge technologies, extensive bioarchives, and commitment to the UN Sustainable Development Goals. Learn about their innovative business pipeline, CRISPR Cas9 Revolution, and ambitious financial targets. Get a glimpse of the future of biotech with BRAIN Biotech AG. Meet Michael Schneiders, IRInnovative Business PipelineThe Future of Biotech ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Embed this episode
Ready to play
BRAIN Biotech AG Deep Dive The CRISPR Cas9 Opportunity with IR
No transcript for this episode yet
Similar Episodes
No similar episodes found.